Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Coherus Oncology Inc NASDAQ:CHRS
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Oppenheimer Initiates a Robust Process with Global Reach for the Benefit of Shareholders -REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. NASDAQ:CHRS today announced that it has initiated the process to market and sell the remaining assets associated with the Compa…